JAK3: expression and mapping to chromosome 19p12-13.1

Area of Science:

• Molecular Biology
• Immunology
• Genetics

Background:

• Janus Kinase 3 (JAK3) is a key intracellular tyrosine kinase in the JAK family.
• It plays a critical role in signal transduction for cytokine receptors sharing the common gamma-chain (gamma[c]), including IL-2, IL-4, IL-7, IL-9, and IL-15.
• JAK3 is essential for normal lymphoid development, as evidenced by severe disruptions in JAK3-null mice and its link to severe combined immunodeficiency (SCID).

Purpose of the Study:

• To characterize the expression profile of JAK3 beyond lymphoid tissues.
• To identify and characterize any novel splice variants of JAK3.
• To determine the chromosomal localization of the JAK3 gene.

Main Methods:

• Cloning of JAK3 from human CD34+ RNA.
• Northern blot analysis to assess tissue expression.
• RNAse protection assays and RT-PCR to analyze expression in cell lines and normal bone marrow.
• Fluorescence in situ hybridization (FISH) for gene localization.

Main Results:

• JAK3 expression is not limited to lymphoid cells but is found in a broad range of hematopoietic and non-hematopoietic tissues, including adult placenta, lung, liver, kidney, and others.
• JAK3 is expressed in the CD34+/lineage- fraction of normal human bone marrow, enriched in hematopoietic stem/progenitor cells.
• A novel splice variant, I-JAK3, formed by splicing with exon II of the Leydig insulin-like (LEY I-L) hormone, is expressed in most tissues that express JAK3.
• JAK3 maps to chromosome 19p12-13.1, colocalizing with the LEY I-L hormone gene.

Conclusions:

• JAK3 has a wider tissue distribution than previously recognized, suggesting broader roles beyond lymphoid development.
• The novel I-JAK3 splice variant is also widely expressed, indicating potential functional significance.
• The gene localization provides insights into the genetic organization and potential regulation of JAK3 and its variants.